Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors

被引:27
作者
Sandalon, Z [1 ]
Bruckheimer, EM [1 ]
Lustig, KH [1 ]
Rogers, LC [1 ]
Peluso, RW [1 ]
Burstein, H [1 ]
机构
[1] Targeted Genet Corp, Seattle, WA 98101 USA
关键词
D O I
10.1128/JVI.78.22.12355-12365.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study evaluated and compared delivery of the tumor necrosis factor alpha receptor (TNFR)-immunoglobulin G1 (IgG1) Fc fusion (TNFR:Fc) gene to the lung by single and repeat administrations of multiple pseudotyped adeno-associated virus (AAV) vectors as a means for achieving systemic distribution of the soluble TNFR:Fc protein. A single endotracheal administration of AAV[2/5]cytomegalovirus (CMV)-TNFR:Fc vector (containing the AAV2 inverted terminal repeats and AAV5 capsid) to the rat lung resulted in long-term, high levels of serum TNFR:Fc protein that gradually declined over a period of 8 months. Endotracheal delivery of AAV[2/1]CMV-TNFR:Fc resulted in serum TNFR:Fc protein levels that were detectable for at least 4 months but were 10-fold lower than that of the AAV [2/5] vector. In contrast, secretion of the TNFR:Fc protein following pulmonary delivery of AAV[2/2]CMV-TNFR:Fc vector was very inefficient, and the protein was detected in the blood only when an airway epithelial cell-specific promoter, CC10, was substituted for the CMV enhancer/promoter to control transgene expression. In the context of AAV[2/5], the CC10 promoter was as efficient as CMV enhancer/promoter in generating similar levels of systemic TNFR:Fc protein, suggesting that this protein is secreted primarily from the airway epithelium. In mice, comparable long-term secretion of TNFR:Fc protein was demonstrated after AAV[2/2] and AAV[2/5] delivery, although the kinetics of transduction appeared to be different. All pseudotyped AAV vectors elicited serum anti-AAV capsid-neutralizing antibody responses, but these did not prevent lung transduction and efficient secretion of TNFR:Fc protein to the circulation following readministration with AAV[2/5]. These results highlight the potential utility of AAV vectors containing serotype 5 capsid to deliver and redeliver genes of secreted proteins to the lung to achieve long-term systemic protein expression.
引用
收藏
页码:12355 / 12365
页数:11
相关论文
共 54 条
[31]   IMMUNOGLOBULIN-G SUBCLASS PROTEINS IN SERUM AND LAVAGE FLUID OF NORMAL SUBJECTS - QUANTITATION AND COMPARISON WITH IMMUNOGLOBULIN-A AND IMMUNOGLOBULIN-E [J].
MERRILL, WW ;
NAEGEL, GP ;
OLCHOWSKI, JJ ;
REYNOLDS, HY .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 131 (04) :584-587
[32]   Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector [J].
Mingozzi, F ;
Schüttrumpf, J ;
Arruda, VR ;
Liu, YH ;
Liu, YL ;
High, KA ;
Xiao, WD ;
Herzog, RW .
JOURNAL OF VIROLOGY, 2002, 76 (20) :10497-10502
[33]   Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis - A multicenter, double-blind, placebo-controlled trial [J].
Moss, RB ;
Rochman, D ;
Spencer, LT ;
Aitken, ML ;
Zeitlhi, PL ;
Waltz, D ;
Milla, C ;
Brody, AS ;
Clancy, JP ;
Ramsey, B ;
Hamblett, N ;
Heald, AE .
CHEST, 2004, 125 (02) :509-521
[34]   Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3 [J].
Muramatsu, S ;
Mizukami, H ;
Young, NS ;
Brown, KE .
VIROLOGY, 1996, 221 (01) :208-217
[35]   Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver [J].
Nakai, H ;
Herzog, RW ;
Hagstrom, JN ;
Walter, J ;
Kung, SH ;
Yang, EY ;
Tai, SJ ;
Iwaki, Y ;
Kurtzman, GJ ;
Fisher, KJ ;
Colosi, P ;
Couto, LB ;
High, KA .
BLOOD, 1998, 91 (12) :4600-4607
[36]   Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo [J].
Nakai, H ;
Fuess, S ;
Storm, TA ;
Meuse, LA ;
Kay, MA .
MOLECULAR THERAPY, 2003, 7 (01) :112-121
[37]   Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 [J].
Qing, K ;
Mah, C ;
Hansen, J ;
Zhou, SZ ;
Dwarki, V ;
Srivastava, A .
NATURE MEDICINE, 1999, 5 (01) :71-77
[38]   Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity [J].
Rabinowitz, JE ;
Rolling, F ;
Li, CW ;
Conrath, H ;
Xiao, WD ;
Xiao, X ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 2002, 76 (02) :791-801
[39]   Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2 [J].
Rutledge, EA ;
Halbert, CL ;
Russell, DW .
JOURNAL OF VIROLOGY, 1998, 72 (01) :309-319
[40]   Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype [J].
Sarkar, R ;
Tetreault, R ;
Gao, GP ;
Wang, LL ;
Bell, P ;
Chandler, R ;
Wilson, JM ;
Kazazian, HH .
BLOOD, 2004, 103 (04) :1253-1260